BMI changes in children and adolescents attending a specialized childhood obesity center: a cohort study

Albane B R Maggio1, Catherine Saunders Gasser, Claudine Gal-Duding

  • 1Pediatric sport medicine and obesity care program, Division of pediatric specialties, Department of Child and Adolescent, University Hospitals of Geneva and University of Geneva, 6, rue Willy-Donzé, 1211, Geneva 14, Switzerland. Albane.maggio@hcuge.ch.

BMC Pediatrics
|December 27, 2013
PubMed

Insights

Individual pediatric obesity intervention significantly reduced BMI z-scores in nearly half of child and adolescent patients, particularly the youngest and most severely obese. This approach offers a simpler alternative to group therapies for managing childhood obesity.

Area of Science:

  • Pediatric Endocrinology
  • Childhood Obesity Management
  • Behavioral Pediatrics

Background:

  • Multidisciplinary group therapies for pediatric obesity are effective but challenging to implement.
  • There is a need for simpler, family-centered obesity management programs.
  • This study evaluates individual family-based intervention for child and adolescent obesity.

Purpose of the Study:

  • To determine changes in Body Mass Index (BMI) z-score following individual family-based obesity intervention.
  • To assess the effectiveness of pediatrician-led intervention in a specialized pediatric obesity center.
  • To identify factors influencing treatment outcomes in pediatric obesity.

Main Methods:

  • A cohort study of 283 pediatric patients (3.3-17.1 years) in a specialized obesity program.
  • Pediatricians utilized an integrative approach including cognitive behavioral techniques and motivational interviewing.
  • Anthropometric data and medical history were assessed; some children received psychological support.

Main Results:

  • A significant decrease in BMI z-score was observed in 49.5% of patients after a mean follow-up of 11.4 months (p < .001).
  • Outcomes were influenced by age, baseline BMI (better in younger, higher BMI patients), and visit frequency (p = .025).
  • Additional psychological intervention showed benefits for children aged 8-11 years (p = .048).

Conclusions:

  • Individual family-based obesity intervention leads to significant weight reduction in approximately half of pediatric patients.
  • The intervention is particularly effective for the youngest and most severely obese children.
  • Trained pediatricians can effectively provide individual follow-up, with psychological support beneficial in select cases.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
828
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.7K